Nature Reviews Cardiology - AOP - nature.com science feeds Nature Reviews Cardiology provides physicians and academics with authoritative and topical discussions of key developments in the field. http://www.nature.com/nrcardio/current_issue/ Nature Publishing Group en © Nature Publishing Group Nature Reviews Cardiology 1759-5002 1759-5010 © Nature Publishing Group permissions@nature.com Nature Reviews Cardiology http://www.nature.com/includes/rj_globnavimages/nrcardio_logo.gif http://www.nature.com/nrcardio/ PET and SPECT in cardiovascular molecular imaging http://feeds.nature.com/~r/nrcardio/rss/aop/~3/26j9XV0aOA8/nrcardio.2009.201 Continuing our series of Reviews on Molecular Imaging, Drs. Dobrucki and Sinusas discuss the applications of PET and single photon emission CT (SPECT) for the evaluation of cardiovascular disease, including myocardial metabolism, neurohumoral activity, atherosclerosis, ventricular remodeling, and angiogenesis. PET and SPECT in cardiovascular molecular imaging

Nature Reviews Cardiology. doi:10.1038/nrcardio.2009.201

Authors: Lawrence W. Dobrucki & Albert J. Sinusas

]]> PET and SPECT in cardiovascular molecular imaging Lawrence W. Dobrucki Albert J. Sinusas doi:10.1038/nrcardio.2009.201 Nature Reviews Cardiology 2009-11-24 Nature Reviews Cardiology 2009-11-24 10.1038/nrcardio.2009.201 http://dx.doi.org/10.1038/nrcardio.2009.201 Review http://dx.doi.org/10.1038/nrcardio.2009.201 Cardiovascular effects of relaxin: from basic science to clinical therapy http://feeds.nature.com/~r/nrcardio/rss/aop/~3/05d0oBKemYI/nrcardio.2009.198 Over the past two decades, there has been rapid progress in our understanding of the pleiotropic actions of relaxin in the cardiovascular system. In this Review, Dr. Du and colleagues discuss basic knowledge of relaxin signaling mechanisms, findings from experimental animal models of cardiovascular diseases, and findings from clinical trials on relaxin. Cardiovascular effects of relaxin: from basic science to clinical therapy

Nature Reviews Cardiology. doi:10.1038/nrcardio.2009.198

Authors: Xiao-Jun Du, Ross A. D. Bathgate, Chrishan S. Samuel, Anthony M. Dart & Roger J. Summers

]]> Cardiovascular effects of relaxin: from basic science to clinical therapy Xiao-Jun Du Ross A. D. Bathgate Chrishan S. Samuel Anthony M. Dart Roger J. Summers doi:10.1038/nrcardio.2009.198 Nature Reviews Cardiology 2009-11-24 Nature Reviews Cardiology 2009-11-24 10.1038/nrcardio.2009.198 http://dx.doi.org/10.1038/nrcardio.2009.198 Review http://dx.doi.org/10.1038/nrcardio.2009.198 Natriuretic peptides in heart failure: should therapy be guided by BNP levels? http://feeds.nature.com/~r/nrcardio/rss/aop/~3/SBxA_bw_7gU/nrcardio.2009.197 The measurement of natriuretic peptides has emerged as an important tool for the diagnosis and risk stratification of patients with heart failure, but the use of these markers for monitoring treatment remains under question. In this Review, Drs. O'Donoghue and Braunwald explore the evolving role of natriuretic peptides in the guidance of heart failure therapy and appraise data from clinical trials in this field. Natriuretic peptides in heart failure: should therapy be guided by BNP levels?

Nature Reviews Cardiology. doi:10.1038/nrcardio.2009.197

Authors: Michelle O'Donoghue & Eugene Braunwald

]]> Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Michelle O'Donoghue Eugene Braunwald doi:10.1038/nrcardio.2009.197 Nature Reviews Cardiology 2009-11-24 Nature Reviews Cardiology 2009-11-24 10.1038/nrcardio.2009.197 http://dx.doi.org/10.1038/nrcardio.2009.197 Review http://dx.doi.org/10.1038/nrcardio.2009.197